How sepsis types affect antibiotic treatment for severe pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study looks at how different types of sepsis affect treatment with the antibiotic piperacillin/tazobactam in patients with severe pneumonia. Researchers hope to find better ways to treat each person based on their specific condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You are in the intensive care unit (ICU) and on at least one form of life support, such as a breathing machine or medicines to keep blood pressure up.
- You are being treated for a known or suspected lung infection (pneumonia).
- You are taking or about to take the antibiotic piperacillin/tazobactam as part of your usual care.
- You need to be able to give permission to join the study, or if you're too unwell, your family or legal representative can give it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
This study looks at how a common antibiotic is removed by kidney dialysis in very ill patients. This may help doctors give the right amount to keep the infection under control.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study is looking at adults with pneumonia to better understand how severe the infection is and how it may affect recovery. By joining, you will help doctors learn more about predicting outcomes for people with similar conditions.
Hear when a new Respiration Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.